Recent Updates
Recently added Catalysts
ANIK Positive Sentiment

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Key Takeaway: Anika Therapeutics, Inc. has announced its participation in the 23rd Annual Needham Virtual Healthcare Conference scheduled for April 8, 2024. The event will include a virtual presentation with a Q&A session at 2:15 PM ET. Anika's involvement highlights their role in the orthopedic field and emphasizes their dedication to advancing joint preservation and early intervention solutions.
Price reaction · baseline $25.7 (2024-04-01 close) · hit after-hours · clean, no other ANIK news in the window
day 0 close
+0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Anika is actively participating in a significant healthcare conference.
  • The company showcases its commitment to orthopedic innovation.
  • Management engagement through virtual presentations promotes transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~168 mo
Minimal dilution risk
Lead asset
Cingal
Phase 3 · Knee Osteoarthritis

Full Press Release Details

BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024. Anika will host a virtual presentation with Q&A starting at 2:15pm ET.
Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.

Frequently Asked Questions

When will Anika Therapeutics participate in the Needham Conference?

Anika Therapeutics will participate on April 8, 2024, at 2:15pm ET.

Where can I find the webcast of Anika's presentation?

The webcast will be available in the Investor Relations section of Anika's website.

What is Anika Therapeutics known for?

Anika Therapeutics specializes in joint preservation and early intervention orthopedic care.

What expertise does Anika leverage in its products?

Anika leverages expertise in hyaluronic acid and implant solutions for its products.

How can I contact Anika's Investor Relations?

You can contact Anika's Investor Relations at 781-457-9287 or via email.

Last updated: Apr 2, 2024